UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Activity of tissue factor in microparticles produced in vitro by endothelial cells, monocytes, granulocytes, and platelets

Biochemistry (Moscow), 2016-02, Vol.81 (2), p.114-121

2016

Volltextzugriff (PDF)

Characteristics of a New DNA Aptamer, Direct Inhibitor of Thrombin

Bulletin of experimental biology and medicine, 2011-02, Vol.150 (4), p.422-425

2011

Volltextzugriff (PDF)

DNA Aptamers to Thrombin Exosite I. Structure-Function Relationships and Antithrombotic Effects

Biochemistry (Moscow), 2019-12, Vol.84 (12-13), p.1521-1528

2019

Volltextzugriff (PDF)

Chromogenic anti-Xa test: the ratio between heparin activity units and concentration of apixaban and rivaroxaban

Aterotromboz (Online), 2020-12 (2), p.96-104

2020

Volltextzugriff (PDF)

Need to determine the residual concentrations of direct oral anticoagulants in patients with atrial fibrillation undergoing transcatheter implantation of the aortic valve

Aterotromboz (Online), 2023-08, Vol.13 (1), p.46-57

2023

Volltextzugriff (PDF)

The fibrinolysis system: regulation of activity and physiologic functions of its main components

Biochemistry (Moscow), 2002-01, Vol.67 (1), p.99-108

2002

Volltextzugriff (PDF)

Modern possibilities and prospects in evaluating the anticoagulant effect of direct oral anticoagulants

Aterotromboz (Online), 2022-06, Vol.12 (1), p.20-28

2022

Volltextzugriff (PDF)

Markers of hemostasis activation and endothelial damage in patients with active cancer

Aterotromboz (Online), 2022-06, Vol.12 (1), p.127-137

2022

Volltextzugriff (PDF)

Growth differentiation factor 15 and the risk of cardiovascular events in patients with atrial fibrillation after elective percutaneous coronary intervention

Rossiĭskiĭ kardiologicheskiĭ zhurnal, 2021-08, Vol.26 (7), p.4457

2021

Volltextzugriff (PDF)

Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Aterotromboz (Online), 2023-01, Vol.12 (2), p.64-78

2023

Volltextzugriff (PDF)

Inhibition of Thrombin Activity with DNA-Aptamers

Bulletin of experimental biology and medicine, 2009-07, Vol.148 (1), p.33-36

2009

Volltextzugriff (PDF)

Relationship between the D-dimer and von Willebrand factor levels and the development of gastrointestinal bleeding in patients with stable coronary artery disease: data from the registry of long-term antithrombotic therapy REGATTA-1

Kardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika, 2021-11, Vol.20 (7), p.3022

2021

Volltextzugriff (PDF)

Venous thrombosis in patients after intracardial catheter interventions: incidence, risk factors, special aspects of the diagnosis

Alʹmanakh klinicheskoĭ medit͡s︡iny, 2019-09, Vol.47 (4), p.326-333

2019

Volltextzugriff (PDF)

Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage

Terapevtic̆eskii arhiv, 2011-01, Vol.83 (6), p.59

2011

Volltextzugriff (PDF)

Effect of fibrinogen on platelet reactivity measured by the VerifyNow P2Y12 assay

Biochemistry (Moscow), 2016-05, Vol.81 (5), p.439-444

2016

Volltextzugriff (PDF)

SCREENING OF CLOTTING SYSTEM DISORDERS BY LABORATORY TESTS

Rossiĭskiĭ kardiologicheskiĭ zhurnal, 2015-11 (3), p.52

2015

Volltextzugriff (PDF)

Prolongation of enoxaparin therapy to one month promotes recanalization of the occlusively thrombosed deep veins

Terapevtic̆eskii arhiv, 2011-01, Vol.83 (8), p.33

2011

Volltextzugriff (PDF)

Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications

Terapevtic̆eskii arhiv, 2011-01, Vol.83 (12), p.43

2011

Volltextzugriff (PDF)

Risk Factors of Recurrent Bleedings at Therapeutic International Normalized Ratio in Patients on Long-Term Warfarin Therapy

Kardiologiia, 2016-02, Vol.2_2016, p.40-46

2016

Volltextzugriff (PDF)

Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis

Terapevtic̆eskii arhiv, 2008-01, Vol.80 (7), p.50

2008

Volltextzugriff (PDF)

GDF-15 and the risk of bleeding in patients with stable CAD receiving multicomponent antithrombotic therapy: the results of the prospective REGATA register

Terapevtic̆eskii arhiv, 2024-07, Vol.96 (7), p.683-689

2024

Volltextzugriff (PDF)

HAS-BLED and HEMORR2HAGES Scales in Assessment of Bleeding Risk in Patients on Long-Term Warfarin Therapy

Kardiologiia, 2015-01, Vol.55 (9), p.50

2015

Volltextzugriff (PDF)

High plasma D-dimer and von Willebrand factor levels are associated with risk of upper gastrointestinal bleeding in patients with chronic coronary syndromes receiving long-term antiplatelet therapy

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease

Terapevtic̆eskii arhiv, 2023-11, Vol.95 (9), p.763-768

2023

Volltextzugriff (PDF)

P5587Elevated D-dimer level after 1 month anticoagulant therapy as a predictor for adverse outcomes in patients with venous thromboembolism: 10-year follow-up results

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(21)

Publikationsform

Artikel
(62)

Sprache

Englisch
(35)
Russisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activity of tissue factor in microparticles produced in vitro by endothelial cells, monocytes, granulocytes, and platelets

Characteristics of a New DNA Aptamer, Direct Inhibitor of Thrombin

DNA Aptamers to Thrombin Exosite I. Structure-Function Relationships and Antithrombotic Effects

Chromogenic anti-Xa test: the ratio between heparin activity units and concentration of apixaban and rivaroxaban

Need to determine the residual concentrations of direct oral anticoagulants in patients with atrial fibrillation undergoing transcatheter implantation of the aortic valve

The fibrinolysis system: regulation of activity and physiologic functions of its main components

Modern possibilities and prospects in evaluating the anticoagulant effect of direct oral anticoagulants

Markers of hemostasis activation and endothelial damage in patients with active cancer

Growth differentiation factor 15 and the risk of cardiovascular events in patients with atrial fibrillation after elective percutaneous coronary intervention

Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Inhibition of Thrombin Activity with DNA-Aptamers

Relationship between the D-dimer and von Willebrand factor levels and the development of gastrointestinal bleeding in patients with stable coronary artery disease: data from the registry of long-term antithrombotic therapy REGATTA-1

Venous thrombosis in patients after intracardial catheter interventions: incidence, risk factors, special aspects of the diagnosis

Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage

Effect of fibrinogen on platelet reactivity measured by the VerifyNow P2Y12 assay

SCREENING OF CLOTTING SYSTEM DISORDERS BY LABORATORY TESTS

Prolongation of enoxaparin therapy to one month promotes recanalization of the occlusively thrombosed deep veins

Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications

Risk Factors of Recurrent Bleedings at Therapeutic International Normalized Ratio in Patients on Long-Term Warfarin Therapy

Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis

GDF-15 and the risk of bleeding in patients with stable CAD receiving multicomponent antithrombotic therapy: the results of the prospective REGATA register

HAS-BLED and HEMORR2HAGES Scales in Assessment of Bleeding Risk in Patients on Long-Term Warfarin Therapy

High plasma D-dimer and von Willebrand factor levels are associated with risk of upper gastrointestinal bleeding in patients with chronic coronary syndromes receiving long-term antiplatelet therapy

Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease

P5587Elevated D-dimer level after 1 month anticoagulant therapy as a predictor for adverse outcomes in patients with venous thromboembolism: 10-year follow-up results

Aktive Filter

Suchergebnisse filtern